SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
RXi Pharmaceuticals Announces Pharmacokinetic Results of Its Single Dose Phase 1 Study With RXI-109 in Healthy Volunteers
Your Message